BNP Paribas Financial Markets’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $171K | Buy |
|
|||||
|
2025
Q2 | $123K | Sell |
|
|||||
|
2025
Q1 | $452K | Sell |
|
|||||
|
2024
Q4 | $743K | Buy |
|
|||||
|
2024
Q3 | $214K | Buy |
|
|||||
|
2024
Q2 | $34K | Sell |
|
|||||
|
2024
Q1 | $1.08M | Sell |
|
|||||
|
2023
Q4 | $1.22M | Buy |
|
|||||
|
2023
Q3 | $406K | Sell |
|
|||||
|
2023
Q2 | $711K | Sell |
|
|||||
|
2023
Q1 | $1.07M | Buy |
|
|||||
|
2022
Q4 | $669K | Sell |
|
|||||
|
2022
Q3 | $1.33M | Buy |
|
|||||
|
2022
Q2 | $263K | Sell |
|
|||||
|
2022
Q1 | $368K | Sell |
|
|||||
|
2021
Q4 | $653K | Sell |
|
|||||
|
2021
Q3 | $1.58M | Buy |
|
|||||
|
2021
Q2 | $484K | Buy |
|
|||||
|
2021
Q1 | $372K | Sell |
|
|||||
|
2020
Q4 | $2.92M | Buy |
|
|||||
|
2020
Q3 | $1M | Sell |
|
|||||
|
2020
Q2 | $3.63M | Sell |
|
|||||
|
2020
Q1 | $3.94M | Buy |
|
|||||
|
2019
Q4 | $4.62M | Buy |
|
|||||
|
2019
Q3 | $213K | Buy |
|
|||||
|
2019
Q2 | $226K | Sell |
|
|||||
|
2019
Q1 | $429K | Buy |
|
|||||
|
2018
Q4 | $59.2K | Sell |
|
|||||
|
2018
Q3 | $156K | Buy |
|
|||||
|
2018
Q2 | $125K | Sell |
|
|||||
|
2018
Q1 | $175K | Buy |
|
|||||
|
2017
Q4 | $187K | Buy |
|
|||||
|
2017
Q3 | $74.1K | Sell |
|
|||||
|
2017
Q2 | $56.3K | Buy |
|
|||||
|
2017
Q1 | $16K | Buy |
|
|||||
|
2016
Q4 | $5.25K | Sell |
|
|||||
|
2016
Q3 | $21K | Buy |
|
|||||
|
2016
Q2 | $6.32K | Buy |
|
|||||
|
2016
Q1 | $518 | Sell |
|
|||||
|
2015
Q4 | $21.8K | Buy |
|